878 results on '"Saura, C."'
Search Results
2. Safety of pregnancy after breast cancer in young women with hormone receptor-positive disease: a systematic review and meta-analysis
3. Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023
4. ESMO Expert Consensus Statements on the management of breast cancer during pregnancy (PrBC)
5. Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial
6. Toxicity, acute
7. Épidémie de rougeole dans un collège d'Auvergne-Rhône-Alpes avec une couverture vaccinale élevée, 2023
8. Genotoxicity of engineered nanomaterials found in the human environment
9. EE528 Analysis of Non-Pharmacological Cost Savings Derived from the Use of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in Patients with HER2-Positive Breast Cancer in Spain
10. Trastuzumab deruxtecan in previously treated patients with HER2-positive metastatic breast cancer: updated survival results from a phase II trial (DESTINY-Breast01)
11. Usefulness of the baseline risk assessment guidelines to predict cancer therapy-related cardiac dysfunction in early-stage HER2 positive breast cancer
12. Sex differences in fear memory consolidation via Tac2 signaling in mice
13. Impact of Engineered Nanomaterials in Genomics and Epigenomics
14. FAIRLANE, a double-blind placebo-controlled randomized phase II trial of neoadjuvant ipatasertib plus paclitaxel for early triple-negative breast cancer
15. Genomic alterations in breast cancer: level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
16. RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer
17. Impact of Engineered Nanomaterials in Genomics and Epigenomics
18. Impact du retrait du port obligatoire du masque à l'école primaire sur l'incidence des infections à SARS-CoV-2 chez les enfants: une étude quasi-expérimentale avec groupe contrôle
19. SA 5.3 What’s next? Antibody-drug conjugates for breast cancer therapy
20. Phase II study of buparlisib (BKM120) and trastuzumab in patients with HER2+ locally advanced or metastatic breast cancer resistant to trastuzumab-based therapy
21. microRNAs: Potential biomarkers of toxicity: A special issue of the journal toxicology reports
22. Stem Cells in Toxicology and Medicine
23. Altered global gene expression profiles in human gastrointestinal epithelial Caco2 cells exposed to nanosilver
24. Genomic and Epigenomic Biomarkers for Predictive Toxicity and Disease
25. Food Antioxidants: Their Dual Role in Carcinogenesis
26. Altered global gene expression profiles in human gastrointestinal epithelial Caco2 cells exposed to nanosilver
27. Gene expression profile at week 2 of neoadjuvant therapy course predicts outcome in HER2-positive breast cancer patients: an explorative analysis from NeoALTTO
28. Cristina Solleiro Thesis 'Impact of female representation in leadership positions on women's leadership tendencies and the mediating role of gender status permeability.' Pre-registartion (Studies 1 and 2)
29. Toxicity, acute
30. Handbook of Nanotoxicology, Nanomedicine and Stem Cell Use in Toxicology
31. Epithelial-Mesenchymal plasticity mediates acquired resistance to eribulin in breast cancer
32. Transition to the new EU CTIS Portal for Regulatory Clinical Trial Submissions: VHIO’s Start-Up Unit Analysis
33. Representation of young adult(19–29 y) and elderly(>75 y) patients populations in an early drug development unit
34. Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle
35. Phase I trial of olaparib in combination with cisplatin for the treatment of patients with advanced breast, ovarian and other solid tumors
36. SEOM clinical guidelines in metastatic breast cancer 2015
37. Toxicology and Epigenetics
38. 87P EPClin vs OncotypeDx in invasive lobular cancer (ILC)
39. 92MO Neoadjuvant nivolumab (NIVO) + palbociclib (PALBO) + anastrozole (ANA) for estrogen receptor-positive (ER+)/human epidermal growth factor receptor 2-negative (HER2−) primary breast cancer (BC): CheckMate 7A8
40. Nanotoxicity: From In Vivo and In Vitro Models to Health Risks
41. Hepatotoxicity: From Genomics to In Vitro and In Vivo Models
42. Genomic and Epigenomic Biomarkers for Predictive Toxicity and Disease
43. Adult intensive-care patients with 2009 pandemic influenza A(H1N1) infection
44. [Untitled]
45. The Human Microbiome: History and Future
46. Genotoxicity of engineered nanomaterials found in the human environment
47. Functional Mapping of AKT Signaling and Biomarkers of Response from the FAIRLANE Trial of Neoadjuvant Ipatasertib plus Paclitaxel for Triple-Negative Breast Cancer
48. 'Nanomaterial-based technologies for determination of food toxicity'
49. microRNAs in Toxicology and Medicine
50. Author Correction: Sex differences in fear memory consolidation via Tac2 signaling in mice.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.